Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Vicore announces initiation of proof-of-concept study for endothelial dysfunction treatments

May 4, 2023 Research and Development Cardiology, Vicore Pharma, clinical trials, endothelial dysfunction, organ damage

Vicore Pharma Holding AB has announced that it has dosed the first patient with C21 in its randomised, double-blind, placebo-controlled, …
News

Eli Lilly shares positive analysis from phase 3 trial for lebrikizumab for atopic dermatitis

May 3, 2023 Research and Development Dermatology, Eli Lilly, Jenny Murase, atopic dermatitis, dermatology, lebrikizumab

Eli Lilly has announced new secondary analysis from its phase 3 clinical development programme for patients with atopic dermatitis (AD) …
News
cdc-d5nff1slguy-unsplash

FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children

April 28, 2023 Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
News
james-yarema-5tymgag0wro-unsplash_1

Daewoong Pharmaceutical and Vitalli Bio enter Global License Agreement for autoimmune disease candidate

April 28, 2023 Research and Development

South Korean Daewoong Pharmaceutical and US biotechnology company Vitalli Bio – a portfolio company of Aditum Bio – have announced …
News
huha-inc-ofvesgqrbjc-unsplash

Eli Lilly’s tirzepatide achieves 15.7% weight loss in adult patients

April 28, 2023 Research and Development

Eli Lilly has announced that tirzepatide (10mg and 15mg) achieved significant and superior weight loss compared to a placebo over …
News

First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

April 27, 2023 Research and Development Avacta

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
News
Press release
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

National Institutes of Health awards grant for gammaCore clinical trial for patients with opioid use disorders

April 27, 2023 Research and Development

Bioelectronic medicine and wellness company electroCore have announced that the National Institute on Drug Abuse (NIDA) part of the National …
News
testalize-me-0je8ynv4mis-unsplash

3B Pharmaceuticals and Novartis enter into licensing agreement for FAP-targeting technology

April 25, 2023 Research and Development

German biotechnology company 3B Pharmaceuticals (3BP) and Switzerland-based Novartis have announced that they have entered into a Global Exclusive Licensing …
News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

AbbVie shares results from phase 3 trial for atogepant migraine treatment

April 24, 2023 Research and Development

AbbVie has shared positive results from its phase 3 ELEVATE study, which assessed atogepant for the preventative treatment of episodic …
News
yunus-tug-lnfgdbcajxu-unsplash

Gamida Cell’s Omisirge receives FDA approval

April 18, 2023 Research and Development

Cell therapy pioneer Gamida Cell has announced FDA approval of its allogeneic cell therapy, Omisirge (omidubicel-onlv), for use in adult …
News
towfiqu-barbhuiya-ssz6x-gao0c-unsplash

GSK announces positive data from phase 3 trial for new UTI antibiotic

April 17, 2023 Research and Development

GSK has shared positive data from its phase 3 trial for gepotidacin as a new oral antibiotic for the treatment …
News
towfiqu-barbhuiya-msqb97guxy0-unsplash

Diabeloop announces collaboration with Novo Nordisk for connected diabetes treatment

April 14, 2023 Research and Development

Automated insulin delivery company Diabeloop has announced its collaboration with global healthcare company Novo Nordisk, with an agreement which covers …
News
steven-hwg-zbsdrthiim4-unsplash

Merck’s relapsing multiple sclerosis trial put on FDA partial clinical hold over liver injuries

April 14, 2023 Research and Development

Merck has announced that its clinical phase 3 study EVOLUTION has been put on partial clinical hold by the FDA …
News
robina-weermeijer-3kgf9r_0ohs-unsplash_2

Biogen announces licensing of Denali’s ATV to target Amyloid Beta

April 13, 2023 Research and Development

Biogen and Denali Therapeutics have announced that Biogen has exercised its option to license Denali’s Antibody Transport Vehicle: Amyloid beta …
News
minku-kang-acnintiifd8-unsplash_1

Aspect Biosystems and Novo Nordisk partner with $75m deal to develop bioprinted tissue therapeutics

April 13, 2023 Research and Development

Canadian biotech company Aspect Biosystems and Denmark-based Novo Nordisk have announced a collaboration, development and license agreement to develop bioprinted …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026